Capital Investment Counsel Inc’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$722K Sell
1,994
-20
-1% -$6.85K 0.08% 110
2026
Q1
$709K Hold
2,014
0.09% 106
2025
Q4
$659K Sell
2,014
-38
-2% -$12.1K 0.08% 109
2025
Q3
$579K Sell
2,052
-400
-16% -$116K 0.07% 114
2025
Q2
$685K Buy
2,452
+100
+4% +$28.3K 0.09% 103
2025
Q1
$733K Sell
2,352
-5
-0.2% -$1.48K 0.11% 94
2024
Q4
$614K Sell
2,357
-33
-1% -$9.79K 0.09% 100
2024
Q3
$770K Sell
2,390
-2,275
-49% -$744K 0.11% 95
2024
Q2
$1.46M Sell
4,665
-100
-2% -$29.4K 0.22% 63
2024
Q1
$1.35M Hold
4,765
0.23% 64
2023
Q4
$1.37M Sell
4,765
-10
-0.2% -$2.73K 0.24% 65
2023
Q3
$1.28M Buy
4,775
+11
+0.2% +$2.75K 0.26% 62
2023
Q2
$1.06M Buy
4,764
+9
+0.2% +$2.09K 0.2% 73
2023
Q1
$1.15M Sell
4,755
-300
-6% -$73.6K 0.26% 69
2022
Q4
$1.33M Buy
5,055
+75
+2% +$20.1K 0.31% 63
2022
Q3
$1.12M Sell
4,980
-170
-3% -$41.2K 0.33% 64
2022
Q2
$1.25M Sell
5,150
-30
-0.6% -$7.35K 0.31% 65
2022
Q1
$1.25M Buy
5,180
+150
+3% +$34.5K 0.26% 67
2021
Q4
$1.13M Buy
5,030
+2,630
+110% +$555K 0.21% 75
2021
Q3
$510K Buy
2,400
+400
+20% +$92.1K 0.11% 104
2021
Q2
$488K Buy
2,000
+500
+33% +$123K 0.11% 105
2021
Q1
$373K Buy
1,500
+300
+25% +$71.6K 0.1% 116
2020
Q4
$276K Hold
1,200
0.09% 123
2020
Q3
$305K Sell
1,200
-30
-2% -$7.43K 0.09% 107
2020
Q2
$290K Hold
1,230
0.11% 97
2020
Q1
$249K Hold
1,230
0.1% 108
2019
Q4
$297K Sell
1,230
-100
-8% -$22K 0.1% 121
2019
Q3
$257K Hold
1,330
0.09% 126
2019
Q2
$245K Hold
1,330
0.09% 128
2019
Q1
$253K Hold
1,330
0.09% 128
2018
Q4
$259K Hold
1,330
0.11% 119
2018
Q3
$276K Sell
1,330
-100
-7% -$19.7K 0.1% 118
2018
Q2
$264K Sell
1,430
-225
-14% -$39.8K 0.11% 119
2018
Q1
$282K Buy
1,655
+100
+6% +$18.4K 0.12% 109
2017
Q4
$270K Sell
1,555
-100
-6% -$17.7K 0.11% 118
2017
Q3
$309K Sell
1,655
-425
-20% -$75.3K 0.13% 107
2017
Q2
$358K Hold
2,080
0.16% 100
2017
Q1
$341K Sell
2,080
-200
-9% -$33.2K 0.15% 101
2016
Q4
$333K Buy
2,280
+200
+10% +$30.1K 0.16% 98
2016
Q3
$347K Sell
2,080
-100
-5% -$16.9K 0.17% 99
2016
Q2
$332K Buy
2,180
+100
+5% +$15.5K 0.17% 97
2016
Q1
$312K Sell
2,080
-500
-19% -$74.3K 0.16% 104
2015
Q4
$419K Hold
2,580
0.22% 91
2015
Q3
$357K Sell
2,580
-125
-5% -$19.7K 0.19% 99
2015
Q2
$415K Sell
2,705
-1,325
-33% -$212K 0.21% 96
2015
Q1
$644K Hold
4,030
0.3% 79
2014
Q4
$642K Sell
4,030
-200
-5% -$31.2K 0.31% 76
2014
Q3
$594K Hold
4,230
0.29% 81
2014
Q2
$501K Sell
4,230
-300
-7% -$34.7K 0.21% 105
2014
Q1
$559K Buy
4,530
+310
+7% +$37.6K 0.25% 95
2013
Q4
$481K Sell
4,220
-400
-9% -$45.5K 0.22% 102
2013
Q3
$517K Hold
4,620
0.26% 92
2013
Q2
$456K Buy
+4,620
New +$479K 0.24% 102

Other funds holding AMGN

Capital Investment Counsel Inc's AMGN Position: Q2 2026 in Review

Capital Investment Counsel Inc reduced its Amgen (AMGN) stake by 0.99% in Q2 2026, selling an estimated $6.85K and leaving 1,994 shares worth $722K. The position accounts for 0.08% of the portfolio, ranked #110.

Capital Investment Counsel Inc first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.46M in Q2 2024. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Capital Investment Counsel Inc held 1,994 shares of Amgen worth $722K as of Q2 2026.
  • Capital Investment Counsel Inc sold 20 Amgen shares in Q2 2026, an estimated $6.85K.
  • Amgen made up 0.08% of Capital Investment Counsel Inc's portfolio in Q2 2026, its #110 holding.
  • Capital Investment Counsel Inc first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Capital Investment Counsel Inc's Amgen position peaked at $1.46M in Q2 2024.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital Investment Counsel Inc's 13F filing for Q2 2026, filed 27 Jul 2026.